Header cover image

French (CAC) Biotech Industry Analysis

UpdatedFeb 24, 2024
DataAggregated Company Financials
Companies27
  • 7D-0.6%
  • 3M-3.2%
  • 1Y-9.5%
  • YTDn/a

Over the last 7 days, the Biotech industry has dropped 3.1%, driven by Valneva declining 12%. The industry has fallen 12% in the last year. Looking forward, earnings are forecast to grow by 28% annually.

Industry Valuation and Performance

Has the French Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 24 Feb 2024€3.1b€558.8m-€674,250,189.6521.7x-4.5x5.5x
Mon, 22 Jan 2024€3.0b€594.4m-€684,098,250.0021.6x-4.4x5.1x
Wed, 20 Dec 2023€3.2b€594.2m-€682,769,096.0022.6x-4.7x5.4x
Fri, 17 Nov 2023€3.3b€588.7m-€672,464,605.0022x-5x5.7x
Sun, 15 Oct 2023€3.1b€806.5m-€616,906,757.0021.1x-5.1x3.9x
Tue, 12 Sep 2023€3.9b€818.0m-€727,959,428.0023.9x-5.3x4.7x
Thu, 10 Aug 2023€3.7b€817.6m-€724,508,043.0024.6x-5.1x4.5x
Sat, 08 Jul 2023€3.7b€818.4m-€736,337,051.0024.9x-5x4.5x
Mon, 05 Jun 2023€3.8b€820.6m-€744,975,967.0025.5x-5x4.6x
Wed, 03 May 2023€3.3b€818.4m-€785,248,469.0028.7x-4.3x4.1x
Fri, 31 Mar 2023€3.2b€959.8m-€687,813,703.0016.5x-4.6x3.3x
Sun, 26 Feb 2023€3.5b€1.0b-€459,287,867.0010.2x-7.6x3.4x
Tue, 24 Jan 2023€3.8b€1.0b-€455,392,294.0013.1x-8.4x3.7x
Thu, 22 Dec 2022€3.4b€1.0b-€456,608,367.0012.4x-7.4x3.3x
Sat, 19 Nov 2022€3.5b€905.6m-€698,054,826.0015.7x-5x3.9x
Mon, 17 Oct 2022€3.7b€924.4m-€707,124,885.0029.8x-5.2x4x
Wed, 14 Sep 2022€4.4b€929.8m-€752,744,320.00111.4x-5.8x4.7x
Fri, 12 Aug 2022€4.6b€972.9m-€658,792,684.00120.9x-6.9x4.7x
Sun, 10 Jul 2022€4.4b€989.1m-€687,154,315.00122.9x-6.4x4.5x
Tue, 07 Jun 2022€4.7b€989.7m-€689,484,895.00135.6x-6.8x4.7x
Thu, 05 May 2022€4.4b€1.0b-€616,800,455.003.3x-7.2x4.4x
Sat, 02 Apr 2022€5.4b€1.2b-€562,111,170.0018x-9.6x4.6x
Mon, 28 Feb 2022€5.1b€939.0m-€675,118,142.0017.7x-7.6x5.5x
Wed, 26 Jan 2022€5.3b€931.4m-€679,725,863.002.8x-7.7x5.6x
Fri, 24 Dec 2021€7.2b€927.7m-€679,920,571.003.6x-10.6x7.8x
Sun, 21 Nov 2021€6.9b€930.3m-€683,744,668.002.6x-10.1x7.4x
Tue, 19 Oct 2021€6.6b€927.3m-€675,157,582.002.4x-9.7x7.1x
Thu, 16 Sep 2021€6.7b€878.8m-€620,422,159.122.8x-10.9x7.7x
Sat, 14 Aug 2021€6.2b€899.6m-€600,532,159.122.6x-10.3x6.9x
Wed, 09 Jun 2021€6.7b€882.0m-€570,006,611.923x-11.8x7.6x
Tue, 02 Mar 2021€7.2b€911.8m-€514,619,691.4222.8x-14x7.9x
Price to Earnings Ratio

-14x


Total Market Cap: €7.2bTotal Earnings: -€514,619,691.42Total Revenue: €911.8mTotal Market Cap vs Earnings and Revenue0%0%0%
French Biotech Industry Price to Earnings3Y Average -7.7x202220232024
Current Industry PE
  • Investors are relatively neutral on the French Biotechnology industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 5.4x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Revenues have also declined 15% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Comparison

How does French Biotech compare with similar industries?

FR Market2.32%
Healthcare2.68%
Biotech-0.61%
Biotech-0.61%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ABVX ABIVAX Société Anonyme€12.208.3%
+€59.1m
79.9%PS38365.8x
MAAT MaaT Pharma€8.7222.8%
+€18.8m
-14.5%PS43.8x
ALSEN Sensorion€0.867.8%
+€17.1m
145.2%PS42.4x
IPH Innate Pharma€2.404.1%
+€7.7m
-13.9%PS3.7x
GNRO GeNeuro€1.3421.4%
+€7.0m
-52.3%PE-3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ALSEN

€0.86

Sensorion

7D

7.8%

1Y

145.2%

GNRO

€1.34

GeNeuro

7D

21.4%

1Y

-52.3%

IVA

€2.93

Inventiva

7D

-2.2%

1Y

-40.2%

VLA

€3.29

Valneva

7D

-10.2%

1Y

-39.3%

ALTME

€0.33

TME Pharma

7D

7.7%

1Y

-73.1%

ABVX

€12.20

ABIVAX Société Anonyme

7D

8.3%

1Y

79.9%

ALACT

€4.95

Acticor Biotech SAS

7D

10.0%

1Y

-48.2%

IPH

€2.40

Innate Pharma

7D

4.1%

1Y

-13.9%

GNFT

€3.32

Genfit

7D

-7.3%

1Y

-17.8%

AELIS

€13.45

Aelis Farma

7D

0.7%

1Y

-5.7%

ADOC

€9.84

Adocia

7D

-2.6%

1Y

203.7%

OSE

€3.25

OSE Immunotherapeutics

7D

-11.7%

1Y

-40.1%

TNG

€1.09

Transgene

7D

-5.2%

1Y

-45.9%

DBV

€1.40

DBV Technologies

7D

-16.3%

1Y

-46.7%

NANO

€6.24

Nanobiotix

7D

-9.8%

1Y

86.8%

MAAT

€8.72

MaaT Pharma

7D

22.8%

1Y

-14.5%